Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11656996 | 0.89 | MAPK1 (0.37) | MAPK1TSHR | |
| SCHEMBL1906158 | 0.86 | MAPK1 (0.42) | MAPK1TSHR | |
| SCHEMBL5354533 | 0.86 | MAPT (0.33) | MAPK1 | |
| SCHEMBL30229 | 0.82 | TSHR (0.36) | MAPK1HSD17B10TSHR | |
| SCHEMBL29884 | 0.79 | MAPK1 (0.42) | MAPK1TSHR | |
| SCHEMBL96705 | 0.78 | TSHR (0.35) | HSD17B10TSHR | |
| SCHEMBL10441310 | 0.77 | HSD17B10 (0.40) | MAPK1HSD17B10TSHR | |
| SCHEMBL5354530 | 0.76 | MAPK1 (0.34) | MAPK1 | |
| SCHEMBL6348131 | 0.76 | MAPK1 (0.34) | MAPK1 | |
| SCHEMBL11659759 | 0.74 | MAPK1 (0.33) | MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780939-B2 | Enhanced heat stability polypropylene | FINA TECHNOLOGY, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| CN-111051370-B | Amphoteric graft copolymer and medical device having enhanced adhesive strength | 贝克顿·迪金森公司 | 2023-01-06 | — | — | CN | disclosed |
| US-11198801-B2 | Amphiphilic graft copolymers and medical devices with enhanced bond strength | BECTON, DICKINSON AND COMPANY (US) | 2021-12-14 | — | — | US | disclosed |
| US-10814040-B2 | Laser markable medical devices | BECTON, DICKINSON AND COMPANY (US) | 2020-10-27 | — | — | US | disclosed |
| US-10806829-B2 | Antimicrobial medical devices | BECTON, DICKINSON AND COMPANY (US) | 2020-10-20 | — | — | US | disclosed |
| WO-2020172387-A9 | ENHANCED HEAT STABILITY POLYPROPYLENE | FINA TECHNOLOGY, INC. (US) | 2020-10-08 | — | — | WO | disclosed |
| US-20200262946-A1 | Enhanced Heat Stability Polypropylene | FINA TECHNOLOGY, INC. | 2020-08-20 | — | — | US | disclosed |
| EP-3668909-A1 | AMPHIPHILIC GRAFT COPOLYMERS AND MEDICAL DEVICES WITH ENHANCED BOND STRENGTH | Becton, Dickinson and Company (US) | 2020-06-24 | — | — | EP | disclosed |
| CN-111051370-A | Amphoteric graft copolymer and medical device having enhanced adhesive strength | 贝克顿·迪金森公司 | 2020-04-21 | — | — | CN | disclosed |
| WO-2019036650-A1 | ANTIMICROBIAL MEDICAL DEVICES | BECTON, DICKINSON AND COMPANY (US) | 2019-02-21 | — | — | WO | disclosed |
| WO-2019036645-A1 | AMPHIPHILIC GRAFT COPOLYMERS AND MEDICAL DEVICES WITH ENHANCED BOND STRENGTH | BECTON, DICKINSON AND COMPANY (US) | 2019-02-21 | — | — | WO | disclosed |
| US-20190055436-A1 | Amphiphilic Graft Copolymers And Medical Devices With Enhanced Bond Strength | BECTON, DICKINSON AND COMPANY | 2019-02-21 | — | — | US | disclosed |
| WO-2019036649-A1 | LASER MARKABLE MEDICAL DEVICES | BECTON, DICKINSON AND COMPANY (US) | 2019-02-21 | — | — | WO | disclosed |
| US-20190054214-A1 | Laser Markable Medical Devices | BECTON, DICKINSON AND COMPANY | 2019-02-21 | — | — | US | disclosed |
| US-20050107558-A1 | Impact copolymer with optimized melt flow, stiffness, and low-temperature impact resistance | FINA TECHNOLOGY, INC. | 2005-05-19 | — | — | US | disclosed |
| US-6599990-B2 | Molecular weight modification of polypropylene by 4-(t-amylperoxy)-4-methyl-2-pentanol and polypropylene so modified suitable for handling and packaging food, beverages and pharmaceuticals and for use in medical devices is disclosed. | ATOFINA CHEMICALS, INC. | 2003-07-29 | — | — | US | disclosed |
| US-20030119997-A1 | Safe, efficient, low t-butanol forming organic peroxide for polypropylene modification | ARKEMA INC. | 2003-06-26 | — | — | US | disclosed |
| US-6503990-B2 | Decreasing molecular weight of polypropylene with 4-(t-amylperoxy)-4-methyl-2-pentanol; product suitable for handling and packaging food, beverages and pharmaceuticals and for use in medical devices | ATOFINA CHEMICALS, INC. | 2003-01-07 | — | — | US | disclosed |
| US-20020137883-A1 | Safe, efficient, low t-butanol forming organic peroxide for polypropylene modification | ARKEMA INC. | 2002-09-26 | — | — | US | disclosed |
| EP-1223178-A1 | Polypropylene modification using organic peroxide | Atofina Chemicals, Inc. (US) | 2002-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10806829-B2 | Antimicrobial medical devices | PPOX, CUTA, PPIA | MAPK1 3835/4885HSD17B10 3816/4885TSHR 2090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.